Defining the Molecular and Radiologic Phenotype of Progressive RA Interstitial Lung Disease (NCT06397677)
Defining the Molecular and Radiologic Phenotype of Progressive RA Interstitial Lung Disease (MOUNTAIN)
🩺 Plain-English Summary (8th-Grade Level)
A study to identify patients with Rheumatoid Arthritis - Associated Interstitial Lung Disease (RA-ILD) that are at the highest risk for progression. The goal of the investigators is to recruit a group of patients with RA-ILD and collect information to help us understand more about disease progression. The investigators will do this using a combination of clinical, radiologic, and biologic features.
Who can join: Review the eligibility criteria below.
Location: University of California San Francisco — San Francisco, California
Age range: 18 Years to 90 Years
🧪 Interventions in This Study
- Research Testing Performed (Laboratory) (GENETIC)
- Information Collected as Standard of Care (DIAGNOSTIC_TEST)
- Research Testing Performed (OTHER)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (4 Sites)
- University of California San Francisco — San Francisco, California
- University of Colorado Denver — Aurora, Colorado
- University of Kansas — Kansas City, Kansas
- University of Michigan — Ann Arbor, Michigan
📞 Contact the Study Coordinator
Phone: (970) 376-8303
Email: haylie.lengel@cuanschutz.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Rheumatoid Arthritis
- Prospective, Multi-Center, Observational, Whole Blood Specimen Collection Study in Participants With Rheumatoid Arthritis With Inadequate Response or Intolerance to a DMARD Starting a New bDMARD or tsDMARD Treatment +/- csDMARD — Phoenix, Arizona
- A Clinical Study to Assess the Efficacy of Cannabigerol in Patients with Active Rheumatoid Arthritis. — Santa Monica, California
- Employment and Arthritis: Making it Work — Richmond, British Columbia
- Brigham and Women's Rheumatoid Arthritis Sequential Study — Boston, Massachusetts
- A Study of Efficacy and Safety of Rosnilimab in Subjects with Moderate to Severe Rheumatoid Arthritis (RENOIR) — Flagstaff, Arizona
- A Study of SPY072 in Rheumatic Disease — Avondale, Arizona
Explore by condition: All Rheumatoid Arthritis clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.